Project Details
Description
Phase III Prospective, Randomized, Double-Blind Registration Study of Lucanix TM (belgenpumatucel-L) vs. Best Supportive Care as Frontline, Adjuvant Therapy for Stages III/IV Non-small Cell Lung Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/08 → 4/30/13 |
Funding
- NOVARX